And looking through Remedy-tinted glasses, it’s also positive that Wolverine is a PlayStation exclusive, so it won’t completely suck the air out of those release weeks across all platforms.
I’m not surprised by the Silent Hill sales; a Japanese horror genre spinoff from a Western team. As a brand, Silent Hill was still quite dead before the 2 Remake and f. Additionally, Silent Hill: The Short Message, released alongside these, seemed to receive a rather critical reception.
Ace Combat has a dedicated fanbase, so it’s worth following the development of its pre-orders over a longer period to see if it appeals to new players as well. Then again, the same applies somewhat to Remedy too.
The small-scale hype around Onimusha is a bit surprising, as I recall those games being something like the “little brothers” of Resident Evil on PS2, with sales declining with each installment. It will certainly get a lot of attention in the wake of Capcom’s “new wave of success” and will succeed commercially, but I don’t see it as a Resident Evil-level competitor for Control Resonant. However, it is the toughest competitor of that week.